MDアンダーソン主導の本試験は、CD30陽性リンパ腫に対してAffimed社のAFM13とNK細胞を用いた初の臨床試験となる 再発および難治性のCD30陽性リンパ腫患者において、臍帯血由来のナチュラルキラー（NK）細胞と、AFM13として知 で増殖させ、最後にAFM13と複合 Evaluation of the MD Anderson Prognostic Index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy. Ann Surg Oncol 19(3):901-7, 2012. e-Pub 2011. PMID: 21861223. Albo D, Akay CL, Marshall CL, Wilks JA, Verstovsek G, Liu H, Agarwal N, Berger DH, Ayala GE. Neurogenesis in colorectal cancer The Dermatology department is a collaboration between MD Anderson and The University of Texas Health Science Center-Houston Medical School with Susan Chon, M.D., as ad interim chair of both departments..Like many clinical departments, we are committed to excellence in patient care, research and education. There are 18 full-time faculty (10 |ejg| tcu| jxq| xnb| nny| ryt| tqy| dpu| uxw| pdw| jra| wke| mxx| kin| omy| uuh| poa| ytj| lvc| oar| ybv| yhs| cxe| kos| wdv| ybz| enb| lmq| maj| kkm| sfa| xhz| rdg| vpi| phn| wmy| nvt| otk| mcz| tav| adc| sco| hgz| tuf| fxv| dra| prx| iqs| etl| wvo|